Seres Therapeutics (MCRB) Prices 10.5M Share Common Offering at $21.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Seres Therapeutics (MCRB) to Offer 8M Common Shares
August 11, 2020 5:48 PM EDTSeres Therapeutics, Inc. (Nasdaq: MCRB) is commencing an underwritten registered public offering of 8,000,000 shares of its common stock. As part of this offering, Seres intends to grant the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of its common... More
Seres Therapeutics (MCRB) Files to Offer 8M Shares of Common Stock
August 11, 2020 5:33 PM EDTSeres Therapeutics (NASDAQ: MCRB) disclosed:
We are offering 8,000,000 shares of our common stock. Our common stock is listed on The Nasdaq Global Select Market, or Nasdaq, under the symbol MCRB. On August 10, 2020, the last reported sale price of our common stock was $22.70 per... More
Seres Therapeutics (MCRB) PT Raised to $24 at Goldman Sachs
August 11, 2020 6:41 AM EDTGoldman Sachs raised its price target on Seres Therapeutics (NASDAQ: MCRB) to $24.00 (from $6.00) while maintaining a Neutral rating.... More
UPDATE: Jefferies Upgrades Seres Therapeutics (MCRB) to Buy
August 11, 2020 4:27 AM EDT(Updated - August 11, 2020 4:48 AM EDT)
(updating comment)
Jefferies analyst Chris Howerton upgraded Seres Therapeutics (NASDAQ: MCRB) from Hold to Buy with a price target of $29.00 (from $4.00).
The analyst comments "Despite ~400% move on positive rCDI data yesterday, we still... More
